Tech Company Financing Transactions
Affix Labs Funding Round
Affix Labs closed a $1.2 million venture capital round on 4/23/2026. Investors included Oost NL, VP Capital and private investors.
Transaction Overview
Company Name
Announced On
4/23/2026
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Undisclosed
Investors
Oost NL (Lead Investor)
VP Capital (Lead Investor)
Proceeds Purpose
The company intends to use the new capital for the rollout of Repeltec in Germany, Austria, France, and Norway, with the UK and Poland to follow, and its patented water-based solubility technology.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
P.O. Box 176
Helsinki, 00101
Finland
Helsinki, 00101
Finland
Phone
Website
Email Address
Overview
We Are Affix Labs: Innovating for a Safer, Greener Future. We are a Dutch green chemistry start-up on a mission to combat disease, reduce harmful pesticide use, and improve quality of life worldwide through next-generation science. Our patented, biodegradable technologies are creating a new standard for safety and sustainability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stijn de Roover
Co-Founder
Lauri Hulkko
Founder
Tom Sam
Browse more venture capital transactions:
Prev: 4/23/2026: Omni Analytics venture capital transaction
Next: 4/23/2026: Maxed Life venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs